Medovex Corp. | Income Statement
Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Sales/Revenue
-
-
-
-
207.30
818.20
Cost of Goods Sold (COGS) incl. D&A
0.50
2.70
6.50
11.30
189.90
526.70
Gross Income
0.50
2.70
6.50
11.30
17.40
291.50
SG&A Expense
672.90
2,934.40
5,531.10
6,390.90
6,078.30
4,985.40
EBIT
673.30
2,937.00
-
6,402.10
6,060.90
4,693.90
Unusual Expense
-
-
-
6,455.60
-
-
Non Operating Income/Expense
-
-
-
-
1.00
52.60
Interest Expense
-
-
46.30
455.30
395.30
162.20
Pretax Income
673.30
2,937.00
5,583.80
13,313.10
6,455.30
4,908.60
Consolidated Net Income
673.30
2,937.00
5,583.80
13,313.10
6,455.30
5,016.30
Net Income
673.30
2,937.00
5,583.80
13,313.10
6,455.30
5,016.30
Net Income After Extraordinaries
673.30
2,937.00
4,644.60
10,398.70
6,454.20
5,016.30
Net Income Available to Common
673.30
2,937.00
6,523.10
15,374.60
6,456.50
5,477.90
EPS (Basic)
0.05
0.37
0.60
1.22
0.34
0.23
Basic Shares Outstanding
12,855.80
7,897.10
10,943.70
13,250.80
19,142.80
23,458.30
EPS (Diluted)
0.05
0.37
0.60
1.22
0.34
0.23
Diluted Shares Outstanding
12,855.80
7,897.10
10,943.70
13,250.80
19,142.80
23,458.30
EBITDA
672.90
2,934.40
5,531.10
6,390.90
6,033.80
4,669.90
About Medovex
View Profile
